Quasi-cubic magnetite/silica core-shell nanoparticles as enhanced mri contrast agents for cancer imaging

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Campbell, Jos L ^a   Arora, Jyoti ^a,b   Cowell, Simon F ^a   Garg, Ashish ^c   Eu, Peter ^b   Bhargava, Suresh K ^a   Bansal, Vipul ^a  

^a RMIT UNIVERSITY   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNETITE NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SILICON DIOXIDE; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG COATING; DRUG STABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SHELF LIFE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ANIMAL; BREAST TUMOR; CHEMISTRY; MALE; METHODOLOGY; NEOPLASM; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; NEOPLASMS; PROSTATIC NEOPLASMS; SILICON DIOXIDE;

EID: 79959793600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021857     Document Type: Article

References (54)

1. Gupta AK, Gupta M, (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomater 26: 3995-4021.
2. Tsang SC, Caps V, Paraskevas I, Chadwick D, Thompsett D, (2004) Magnetically separable, carbon-supported nanocatalysts for the manufacture of fine chemicals. Angew Chem Inter Ed 43: 5645-5649.
3. Chikazumi S, Taketomi S, Ukita M, Mizukami H, Miyajima M, et al. (1987) Physics of magnetic fluids. J Magn Magn Mater 65: 245-251.
4. Rai K, Moskowitz R, (1990) Commercial applications of ferrofluids. J Magn Magn Mater 85: 233-235.
5. Losic D, Yu Y, Aw MS, Simovic S, Thierry B, et al. (2010) Surface functionalisation of diatoms with dopamine modified iron-oxide nanoparticles: towards magnetically guided drug microcarriers with biologically derived morphologies. Chem Commun 46: 6323-6325.
6. Talelli M, Rijcken CJF, Lammers T, Seevinck PR, Strorm G, et al. (2009) Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir 25: 2060-2067.
7. Chen T-J, Cheng T-H, Chen C-Y, Hsu SCN, Cheng T-L, et al. (2009) Targeted herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI. J Biol Inorg Chem 14: 253-260.
8. van Straaten ECW, Scheltens P, Barkhof F, (2004) MRI and CT in the diagnosis of vascular dementia. J Neurol Sci 226: 9-12.
9. Saini A, Saifuddin A, (2004) MRI of osteonecrosis. Clin Radiol 59: 1079-1093.
10. Suzuki K, Yamamoto M, Hasegawa Y, Ando M, Shima K, et al. (2004) Magnetic resonance imaging and computed tomography in the diagnoses of brain metastases of lung cancer. Lung Canc 46: 357-360.
11. High WA, Ayers RA, Chandler J, Zito G, Cowper SE, (2007) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56: 21-26.
12. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE, (2007) Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiol 242: 647-649.
13. Kanal E, Broome DR, Martin DR, Thomsen HS, (2008) Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. Radiol 246: 11-14.
14. Taboada E, Solanas R, Rodriguez E, Weissleder R, Roig A, (2009) Supercritical-fluid-assisted one-pot synthesis of biocompatible core(gamma-Fe2O3)/shell(SiO2) nanoparticles as high relaxivity T2-contrast agents for magnetic resonance imaging. Adv Funct Mater 19: 2319-2324.
15. Tanaka K, Narita A, Kitamura N, Uchiyama W, Morita M, et al. (2010) Preparation for highly sensitive MRI contrast agents using core/shell type nanoparticles consisting of multiple SPIO cores with thin silica coating. Langmuir 26: 11759-11762.
16. Wan J, Meng X, Liu E, Chen K, (2010) Incorporation of magnetite nanoparticle clusters in fluorescent silica nanoparticles for high-performance brain tumor delineation. Nanotechnol 21: 235104-235112.
17. Bharde A, Rautaray D, Bansal V, Ahmad A, Sarkar I, et al. (2006) Extracellular synthesis of magnetite using fungi. Small 2: 135-141.
18. Bansal V, Ramanathan R, Bhargava S, (2011) Fungus-mediated biological approaches towards 'green' synthesis of oxide nanomaterials. Aus J Chem 64: 279-293.
19. Kobayashi H, Brechbiel MW, (2005) Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 57: 2271-2286.
20. Martina MS, Fortin JP, Menager C, Clement O, Barratt G, et al. (2005) Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. J Am Chem Soc 127: 10676-10685.
21. Mulder WJM, Strijkers GJ, van Tilborg GAF, Griffioen AW, Nicolay K, (2006) Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 19: 142-164.
22. Lu J, Ma SL, Sun JY, Xia CC, Liu C, et al. (2009) Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging. Biomaterials 30: 2919-2928.
23. Tromsdorf UI, Bigall NC, Kaul MG, Bruns OT, Nikolic MS, et al. (2007) Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett 7: 2422-2427.
24. Lee J-H, Huh Y-M, Jun Y-w, Seo J-w, Jang J-t, et al. (2007) Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nature Medicine 13: 95-99.
25. Sun S, Zeng H, Robinson DB, Raoux S, Rice PM, et al. (2003) Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 126: 273-279.
26. Yoon T-J, Yu KN, Kim E, Kim JS, Kim BG, et al. (2006) Specific targeting, cell sorting, and bioimaging with smart magnetic silica core-shell nanomaterials. Small 2: 209-215.
27. Bardhan R, Chen W, Perez-Torres C, Bartels M, Huschka RM, et al. (2009) Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic responses. Adv Func Mater 19: 3901-3909.
28. Hilger I, Trost R, Reichenbach JR, Linb W, Lisy M-R, et al. (2007) MR imaging of Her-2/neu protein using magnetic nanoparticles. Nanotechnol 13: 135103-135110.
29. Goloverda G, Jackson B, Kidd C, Kolesnichenko V, (2009) Synthesis of ultrasmall magnetic iron oxide nanoparticles and study of their colloid and surface chemistry. J Magn Magn Mater 321: 1372-1376.
30. Babes L, Denizot B, Tanguy G, Jeune JJLe, Jallet P, (1999) Synthesis of iron oxide nanoparticles used as MRI contrast agents: a parametric study. J Colloid Interface Sci 212: 474-482.
31. Yu X, Song SK, Chen JJ, Scott MJ, Fuhrhop RJ, et al. (2000) High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 44: 867-872.
32. Jun YW, Lee JH, Cheon J, (2007) Nanoparticle contrast agents for molecular magnetic resonance imaging in Nanobiotechnology II, Wiley, 321-340.
33. Paul KG, Frigo TB, Groman JY, Groman EV, (2004) Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. Bioconjugate Chem 15: 394-401.
34. Lu AH, Salabas EL, Schuth F, (2007) Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Inter Ed 46: 1222-1244.
35. Vogl TJ, Schwarz W, Blume S, Pietsch M, Shamsi K, et al. (2003) Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 13: 262-272.
36. Ohmori M, Matijevic E, (1993) Preperation and properties of uniform inorganic colloidal particles silica on iron. J Colloid Interf Sci 160: 288-292.
37. Ohmori M, Matijevic E, (1992) Preperation and properties of uniform coated colloidal particles silica on hematite. J Colloid Interf Sci 150: 594-598.
38. Murakami Y, Kenjo A, Sadoh T, Yoshitake T, Miyao M, (2004) Solid-phase crystallization of [beta]-FeSi2 thin film in Fe/Si structure. Thin Solid Films 461: 68-71.
39. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, et al. (2005) Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview. Langmuir 21: 10644-10654.
40. Alberola AP, Rädler JO, (2009) The defined presentation of nanoparticles to cells and their surface controlled uptake. Biomater 30: 3766-3770.
41. Nel A, Xia T, Madler L, Li N, (2006) Toxic potential of materials at the nanolevel. Science 311: 622-627.
42. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, et al. (1989) Superparamagnetic iron oxide- pharmacokinetics and toxicity. Am J Roentgenol 152: 167-173.
43. Jun Y-w, Huh Y-M, Choi J-s, Lee J-H, Song H-T, et al. (2005) Nanoscale size effects of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc 127: 5732-5733.
44. Koenig SH, Kellar KE, (1995) Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med 34: 227-233.
45. Wang YXJ, Hussain SM, Krestin GP, (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11: 2319-2331.
46. Müller K, Skeppper JN, Posfai M, Trivedi R, Howarth S, et al. (2007) Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomater 28: 1629-1642.
47. Wuang SC, Neoh KG, Kang ET, Pack DW, Leckband DE, (2008) HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization. Biomater 29: 2270-2279.
48. Mansoor A, (2007) Nanotechnology for Cancer Therapy, 1 ed., CRC Press, pp. 201-210.
49. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, et al. (1995) Vascular-permeability in a human tumor xenograft- molecular size dependence and cutoff size. Canc Res 55: 3752-3756.
50. Sivakumar S, Bansal V, Cortez C, Chong SF, Zelikin AN, et al. (2009) Degradable, surfactant-free, monodisperse polymer-encapsulated emulsions as anticancer drug carriers. Adv Mater 21: 1820-1824.
51. Wang Y, Bansal V, Zelikin AN, Caruso F, (2008) Templated synthesis of single-component polymer capsules and their application in drug delivery. Nano Lett 8: 1741-1745.
52. Park J, An KJ, Hwang YS, Park J-G, Noh H-J, et al. (2004) Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 3: 891-895.
53. Fang CL, Qian K, Zhu J, Wang S, Lv X, Yu SH, (2008) Monodisperse α-Fe2O3@SiO2@Au core/shell nanocomposite spheres: synthesis, characterization and properties. Nanotechnol 19: 125601-125607.
54. Morel AL, Nikitenko SI, Gionnet K, Wattiaux A, Lai-Kee-Him J, et al. (2008) Sonochemical approach to the synthesis of Fe3O4@SiO2 core-shell nanoparticles with tunable properties. ACS Nano 2: 847-856.